| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $31.50B | +9.7% |
| Cost of Revenue | $20.18B | +15.6% |
| Gross Profit | $11.31B | +0.5% |
| R&D Expense | $346.0M | -0.3% |
| SG&A Expense | $7.38B | +17.9% |
| Operating Income | $3.53B | -24.0% |
| Interest Expense | $428.0M | +17.3% |
| Pre-tax Income | $3.23B | -26.1% |
| Income Tax | $865.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $3.09B | +32.1% |
| Inventory | $3.38B | +24.9% |
| Current Assets | $10.09B | -2.4% |
| Total Assets | $71.16B | +6.1% |
| Current Liabilities | $16.73B | +19.4% |
| Long-term Debt | $20.25B | +15.4% |
| Total Liabilities | $44.24B | +14.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.91B | -5.6% |
| Capital Expenditures | $906.0M | -6.1% |
| Investing Cash Flow | -$4.89B | — |
| Financing Cash Flow | -$456.0M | +88.8% |
| Free Cash Flow | $3.00B | -5.5% |
| -27.3% |
| Net Income | $2.72B | -36.8% |
| EPS (Basic) | $1.97 | -35.6% |
| EPS (Diluted) | $1.96 | -35.5% |
| Stockholders' Equity |
| $26.88B |
| -4.9% |